vs
Side-by-side financial comparison of Karman Holdings Inc. (KRMN) and PROCEPT BioRobotics Corp (PRCT). Click either name above to swap in a different company.
Karman Holdings Inc. is the larger business by last-quarter revenue ($134.5M vs $83.1M, roughly 1.6× PROCEPT BioRobotics Corp). Karman Holdings Inc. runs the higher net margin — 5.7% vs -38.1%, a 43.8% gap on every dollar of revenue. On growth, Karman Holdings Inc. posted the faster year-over-year revenue change (47.4% vs 20.2%). Over the past eight quarters, Karman Holdings Inc.'s revenue compounded faster (27.3% CAGR vs 24.8%).
Karman Holdings is an American fabricator of space and defense systems based in Huntington Beach, California. The company, which is valued at approximately US$4 billion, recently underwent an initial public offering.
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
KRMN vs PRCT — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $134.5M | $83.1M |
| Net Profit | $7.7M | $-31.6M |
| Gross Margin | 39.9% | 64.9% |
| Operating Margin | 15.7% | -4.1% |
| Net Margin | 5.7% | -38.1% |
| Revenue YoY | 47.4% | 20.2% |
| Net Profit YoY | 358.3% | -27.9% |
| EPS (diluted) | $0.06 | $-0.56 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $83.1M | ||
| Q4 25 | $134.5M | $76.4M | ||
| Q3 25 | $121.8M | $83.3M | ||
| Q2 25 | $115.1M | $79.2M | ||
| Q1 25 | $100.1M | $69.2M | ||
| Q4 24 | $91.2M | $68.2M | ||
| Q3 24 | $86.0M | $58.4M | ||
| Q2 24 | $85.0M | $53.4M |
| Q1 26 | — | $-31.6M | ||
| Q4 25 | $7.7M | $-29.8M | ||
| Q3 25 | $7.6M | $-21.4M | ||
| Q2 25 | $6.8M | $-19.6M | ||
| Q1 25 | $-4.8M | $-24.7M | ||
| Q4 24 | $1.7M | $-18.9M | ||
| Q3 24 | $4.3M | $-21.0M | ||
| Q2 24 | $4.6M | $-25.6M |
| Q1 26 | — | 64.9% | ||
| Q4 25 | 39.9% | 60.6% | ||
| Q3 25 | 41.0% | 64.8% | ||
| Q2 25 | 40.9% | 65.4% | ||
| Q1 25 | 39.4% | 63.9% | ||
| Q4 24 | 38.1% | 64.0% | ||
| Q3 24 | 39.3% | 63.2% | ||
| Q2 24 | 40.7% | 59.0% |
| Q1 26 | — | -4.1% | ||
| Q4 25 | 15.7% | -40.6% | ||
| Q3 25 | 17.9% | -27.8% | ||
| Q2 25 | 17.5% | -28.0% | ||
| Q1 25 | 10.0% | -39.7% | ||
| Q4 24 | 15.8% | -28.9% | ||
| Q3 24 | 20.2% | -38.4% | ||
| Q2 24 | 21.5% | -50.3% |
| Q1 26 | — | -38.1% | ||
| Q4 25 | 5.7% | -39.1% | ||
| Q3 25 | 6.3% | -25.7% | ||
| Q2 25 | 5.9% | -24.7% | ||
| Q1 25 | -4.8% | -35.8% | ||
| Q4 24 | 1.8% | -27.6% | ||
| Q3 24 | 5.0% | -35.9% | ||
| Q2 24 | 5.4% | -48.0% |
| Q1 26 | — | $-0.56 | ||
| Q4 25 | $0.06 | $-0.54 | ||
| Q3 25 | $0.06 | $-0.38 | ||
| Q2 25 | $0.05 | $-0.35 | ||
| Q1 25 | $-0.04 | $-0.45 | ||
| Q4 24 | $0.01 | $-0.34 | ||
| Q3 24 | $0.03 | $-0.40 | ||
| Q2 24 | $0.03 | $-0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $34.0M | $245.6M |
| Total DebtLower is stronger | — | $51.7M |
| Stockholders' EquityBook value | $382.7M | $347.7M |
| Total Assets | $1.1B | $487.1M |
| Debt / EquityLower = less leverage | — | 0.15× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $245.6M | ||
| Q4 25 | $34.0M | $286.5M | ||
| Q3 25 | $18.7M | $294.3M | ||
| Q2 25 | $27.4M | $302.7M | ||
| Q1 25 | $113.7M | $316.2M | ||
| Q4 24 | $11.5M | $333.7M | ||
| Q3 24 | — | $196.8M | ||
| Q2 24 | — | $214.1M |
| Q1 26 | — | $51.7M | ||
| Q4 25 | — | $51.6M | ||
| Q3 25 | — | $51.6M | ||
| Q2 25 | — | $51.5M | ||
| Q1 25 | — | $51.5M | ||
| Q4 24 | — | $51.5M | ||
| Q3 24 | — | $51.4M | ||
| Q2 24 | — | $51.4M |
| Q1 26 | — | $347.7M | ||
| Q4 25 | $382.7M | $365.9M | ||
| Q3 25 | $369.1M | $380.3M | ||
| Q2 25 | $361.5M | $385.8M | ||
| Q1 25 | $348.9M | $389.2M | ||
| Q4 24 | $196.0M | $402.2M | ||
| Q3 24 | $194.1M | $241.2M | ||
| Q2 24 | $189.6M | $251.8M |
| Q1 26 | — | $487.1M | ||
| Q4 25 | $1.1B | $508.1M | ||
| Q3 25 | $968.1M | $511.5M | ||
| Q2 25 | $953.9M | $513.1M | ||
| Q1 25 | $875.4M | $519.4M | ||
| Q4 24 | $774.0M | $534.0M | ||
| Q3 24 | — | $374.1M | ||
| Q2 24 | — | $374.4M |
| Q1 26 | — | 0.15× | ||
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.14× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 0.13× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.20× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $8.7M | — |
| Free Cash FlowOCF − Capex | $4.0M | — |
| FCF MarginFCF / Revenue | 3.0% | — |
| Capex IntensityCapex / Revenue | 3.5% | — |
| Cash ConversionOCF / Net Profit | 1.13× | — |
| TTM Free Cash FlowTrailing 4 quarters | $-42.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $8.7M | $-10.3M | ||
| Q3 25 | $131.0K | $-6.6M | ||
| Q2 25 | $-17.4M | $-15.0M | ||
| Q1 25 | $-13.6M | $-17.0M | ||
| Q4 24 | — | $-32.4M | ||
| Q3 24 | — | $-18.8M | ||
| Q2 24 | — | $-15.7M |
| Q1 26 | — | — | ||
| Q4 25 | $4.0M | $-12.2M | ||
| Q3 25 | $-6.8M | $-9.5M | ||
| Q2 25 | $-21.0M | $-17.8M | ||
| Q1 25 | $-18.6M | $-18.8M | ||
| Q4 24 | — | $-33.6M | ||
| Q3 24 | — | $-19.0M | ||
| Q2 24 | — | $-16.8M |
| Q1 26 | — | — | ||
| Q4 25 | 3.0% | -15.9% | ||
| Q3 25 | -5.6% | -11.4% | ||
| Q2 25 | -18.2% | -22.5% | ||
| Q1 25 | -18.6% | -27.2% | ||
| Q4 24 | — | -49.2% | ||
| Q3 24 | — | -32.6% | ||
| Q2 24 | — | -31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 3.5% | 2.4% | ||
| Q3 25 | 5.7% | 3.4% | ||
| Q2 25 | 3.2% | 3.5% | ||
| Q1 25 | 5.0% | 2.7% | ||
| Q4 24 | — | 1.7% | ||
| Q3 24 | — | 0.4% | ||
| Q2 24 | — | 2.0% |
| Q1 26 | — | — | ||
| Q4 25 | 1.13× | — | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | -2.55× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
KRMN
| Tactical Missile And Integrated Defense Systems | $50.5M | 38% |
| Hypersonic And Strategic Missile Defense | $48.4M | 36% |
| Space And Launch | $35.7M | 27% |
PRCT
| Handpieces and other consumables | $43.0M | 52% |
| System sales and rentals | $23.4M | 28% |
| Other | $11.1M | 13% |
| Service | $5.6M | 7% |
